Pfortmueller, Carmen A. http://orcid.org/0000-0003-0326-2770
Messmer, Anna S.
Hess, Benjamin
Reineke, David
Jakob, Laura
Wenger, Stefanie
Waskowski, Jan
Zuercher, Patrick
Stoehr, Frederik
Erdoes, Gabor
Luedi, Markus M.
Jakob, Stephan M.
Englberger, Lars
Schefold, Joerg C.
Funding for this research was provided by:
Schweizerische Herzstiftung (N/A)
Novartis Stiftung für Medizinisch-Biologische Forschung (17C144)
Scherbarth Stiftung (N/A)
B. Braun-Stiftung (BBST-D-17-00069)
Article History
Received: 7 January 2019
Accepted: 9 May 2019
First Online: 14 June 2019
Ethics approval and consent to participate
: This study was approved by the cantonal committee responsible for ethical research in humans (Kantonale Ethikkommission, KEK, Bern Switzerland, approval number 2017-00647). Informed consent is provided by all participants or their legal representatives.
: Not applicable.
: The Department of Intensive Care Medicine (CAP, ASM, BH, LJ, SW, SMJ, JCS) has, or has had, research and/or development/consulting contracts with (full disclosure) Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, the Swiss Center for Electronics and Microtechnology (CSEM SA), Edwards Lifesciences Services GmbH/SA, Kenta Biotech Ltd., Maquet Critical Care AB, Omnicare Clinical Research AG, and Nestlé. Educational grants were received from Fresenius Kabi, GlaxoSmithKline (GSK), Merck Sharp & Dohme (MSD), Lilly, Baxter, Astellas, AstraZeneca, B. Braun Medical AG, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma (Roba Pharma), Pfizer, and Orion Pharma. No personal financial gains resulted from the respective development/consulting contracts and/or educational grants. The other authors declare that they have no competing interests.